» Articles » PMID: 22832815

Post-traumatic Anxiety Associates with Failure of the Innate Immune Receptor TLR9 to Evade the Pro-inflammatory NFκB Pathway

Overview
Date 2012 Jul 27
PMID 22832815
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Post-traumatic anxiety notably involves inflammation, but its causes and functional significance are yet unclear. Here, we report that failure of the innate immune system Toll-like receptor 9 (TLR9) to limit inflammation is causally involved with anxiety-associated inflammation and that peripheral administration of specific oligonucleotide activators of TLR9 may prevent post-traumatic consequences in stressed mice. Suggesting involvement of NFκB-mediated enhancement of inflammatory reactions in the post-traumatic phenotype, we found association of serum interleukin-1β increases with symptoms severity and volumetric brain changes in post-traumatic stress disorder patients. In predator scent-stressed mice, the moderate NFκB-activating oligonucleotides mEN101 and its human ortholog BL-7040, but not the canonic NFκB activator oligonucleotide ODN1826, induced anxiolytic effects. In stressed mice, peripherally administered mEN101 prevented delayed stress-inducible serum interleukin-1β increases while limiting stress-characteristic hippocampal transcript modifications and the anxiety-induced EGR1-mediated neuronal activation. Attesting to the TLR9 specificity of this response, BL-7040 suppressed NFκB-mediated luciferase in transfected cells co-expressing TLR9, but not other TLRs. Furthermore, TLR9-/- mice were mEN101 and BL-7040 resistant and presented unprovoked anxiety-like behavior and anxiety-characteristic hippocampal transcripts. Our findings demonstrate functional relevance of TLR9 in protecting stressed mammals from overreacting to traumatic experiences and suggest using oligonucleotide-mediated peripheral TLR9 activation to potentiate the innate immune system and prevent post-traumatic inflammation and anxiety.

Citing Articles

The Impact of Seasonality on Mental Health Disorders: A Narrative Review and Extension of the Immunoseasonal Theory.

Modzelewski S, Naumowicz M, Suprunowicz M, Oracz A, Waszkiewicz N J Clin Med. 2025; 14(4).

PMID: 40004649 PMC: 11856923. DOI: 10.3390/jcm14041119.


Formation of memory assemblies through the DNA-sensing TLR9 pathway.

Jovasevic V, Wood E, Cicvaric A, Zhang H, Petrovic Z, Carboncino A Nature. 2024; 628(8006):145-153.

PMID: 38538785 PMC: 10990941. DOI: 10.1038/s41586-024-07220-7.


Basal forebrain cholinergic systems as circuits through which traumatic stress disrupts emotional memory regulation.

Knox D, Parikh V Neurosci Biobehav Rev. 2024; 159:105569.

PMID: 38309497 PMC: 10948307. DOI: 10.1016/j.neubiorev.2024.105569.


Metabolic and immune dysfunctions in post-traumatic stress disorder: what can we learn from animal models?.

Lushchak O, Orru M, Strilbytska O, Berezovskyi V, Cherkas A, Storey K EXCLI J. 2023; 22:928-945.

PMID: 38023568 PMC: 10630527. DOI: 10.17179/excli2023-6391.


Mitochondrial dysfunction as a possible trigger of neuroinflammation at post-traumatic stress disorder (PTSD).

Dmytriv T, Tsiumpala S, Semchyshyn H, Storey K, Lushchak V Front Physiol. 2023; 14:1222826.

PMID: 37942228 PMC: 10628526. DOI: 10.3389/fphys.2023.1222826.


References
1.
Bonne O, BRANDES D, Gilboa A, Gomori J, Shenton M, Pitman R . Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am J Psychiatry. 2001; 158(8):1248-51. PMC: 2819102. DOI: 10.1176/appi.ajp.158.8.1248. View

2.
Schmidt E, Aguilera G, Binnekade R, Tilders F . Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience. 2003; 116(1):275-83. DOI: 10.1016/s0306-4522(02)00555-9. View

3.
Puccetti P, Grohmann U . IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol. 2007; 7(10):817-23. DOI: 10.1038/nri2163. View

4.
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

5.
Krieg A . Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006; 5(6):471-84. DOI: 10.1038/nrd2059. View